Postthrombotic Syndrome: Clinical Trials

72 trials for Postthrombotic Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

33 completed, 12 unknown, 11 recruiting, 6 terminated. 28 Not applicable, 12 Phase 3, 7 Phase 4, 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable28Completed 12, Recruiting 6, Terminated 4, Unknown 3, Active not recruiting 1, Not yet recruiting 1, Withdrawn 1
Phase 312Completed 6, Not yet recruiting 2, Recruiting 2, Unknown 1, Withdrawn 1
Phase 47Completed 3, Terminated 2, Unknown 1, Withdrawn 1
Phase 22Unknown 2
Phase 11Unknown 1

Follow Postthrombotic Syndrome: new trials by email Literature Review of Postthrombotic Syndrome trials Research Report on Postthrombotic Syndrome

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Vflower Stent System for Iliofemoral Vein Stenosis and Occlusion: A Multicenter Real-World Study
Vflower venous stent system (self-expanding nitinol stent for iliofemoral venous lesions) - Iliofemoral Vein Stenosis, Iliofemoral Vein Occlusion
Not yet recruitingShanghai General Hospital, Shanghai Jiao Tong University School of Medicine3102026-10-012026-09-09
PROfunda Femoris Vein Thrombosis Evaluation and Clearance to Improve Outcomes of Endovascular Treatment for Acute Iliofemoral Deep Vein Thrombosis
Endovascular treatment with profunda femoris vein thrombosis clearance (Endovascular treatment with PFV-TC), Percutaneous mechanical thrombectomy without profunda femoris vein thrombosis clearance (PMT without PFV-TC) - Deep Vein Thrombosis
Not applicableRecruitingRenJi Hospital1402026-06-242026-10-13
Design and Rationale of the COLT Study
Colchicine 0.5 MG Oral Tablet, Placebo - Venous Thrombosis Deep (Limbs), Post-thrombotic Syndrome
Phase 3Not yet recruitingAzienda Sanitaria Locale ASL 6, Livorno9402026-06-012026-02-25
Acute or Subacute Iliofemoral Vein Thrombosis: Aspiration for Flow Restoration Versus Standard Anticoagulation
Thrombosis aspiration - Deep Vein Thrombosis of Lower Limb, Postthrombotic Syndrome
Not applicableNot yet recruitingWeiwei Wu1042026-05-012026-05-07
Incidence and Characteristic of CRT Persistent After Catheter Extraction in ICU Patients
No Interventions - Catheter Thrombosis, Post Thrombotic Syndrome
Not yet recruitingMasarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s.3002026-04-012026-03-16
RECANA OUS - Recana Thrombectomy Catheter System for Venous Obstruction and Occlusion Study (RECANA-OUS-UK)
Recana Thrombectomy Catheter System - Venous Obstruction
Not applicableRecruitingIntervene, Inc.302025-10-182026-05-06
Colchicine to Quench the Inflammatory Response After Deep Vein Thrombosis (The Conquer-DVT Pilot Trial)
Colchicine 0.5 mg po, Placebo 0.5 mg po - Venous Thromboembolism
Phase 3RecruitingOttawa Hospital Research Institute1502025-07-072026-07-23
RECANA OUS - Recana Thrombectomy Catheter System for Venous Obstruction and Occlusion Study (RECANA-OUS-IRL)
Recana procedure - Venous Obstruction
Not applicableRecruitingIntervene, Inc.202025-07-022026-05-27
Immunosuppressive Therapy Alone Versus Plus Oral Anticoagulation in the Treatment of VT Associated With Behcet's Disease
Placebo plus immunosuppression, Rivaroxaban plus immunosupression - Behcet Disease, Behcet Disease and Vascular Involvement
Phase 3Not yet recruitingMarmara University1102025-04-302025-04-13
Outcomes of Iliac Vein Stenting With Dedicated Venous Stents in Treatment of Chronic Post-thrombotic Venous Ulcers
dedicated venous stenting, Dedicated venous stent / iliofemoral dedicated venous stenting - Vascular, DVT - Deep Vein Thrombosis
Not applicableRecruitingAin Shams University202025-03-022026-08-13
Grade Analysis of Veins by MRI and CT in Post-Thrombotic Syndrome
Lower Limb Venous Thrombosis
CompletedUniversity Hospital, Bordeaux502024-10-302025-06-22
DVT Burden and the Risk of Post-thrombotic Syndrome
Quantification of deep vein thrombosis burden and assessment of post-thrombotic syndrome - Postthrombotic Syndrome
Not applicableRecruitingCentre Hospitalier Intercommunal de Toulon La Seyne sur Mer4002024-06-052026-07-07
Comparison Of Different Mechanical Thrombectomy Devices in Endovascular Treatment of Acute Iliofemoral Venous Thrombosis
Percutaneous mechanical thrombectomy by ClotTriever System, Percutaneous mechanical thrombectomy by aspiration or rheolytic thrombectomy - Deep Vein Thrombosis
RecruitingRenJi Hospital1802024-01-012026-06-03
Structured Exercise Versus Endovascular Reconstruction in Post Thrombotic Syndrome
exercise, Deep venous stenting - Post Thrombotic Syndrome
Not applicableUnknownGuy's and St Thomas' NHS Foundation Trust542023-09-052023-09-13
Long-Term Post Thrombotic Syndrome Assessment (CELEST Long Term).
Phone call - Post Thrombotic Syndrome
UnknownLaboratoires Innothera2882023-07-242023-09-21
Exercise Tolerance After Venous Recanalization for Post-thrombotic Syndrome
Stress test - Post Thrombotic Syndrome, Venous Thromboses
Not applicableCompletedUniversity Hospital, Montpellier222023-04-172025-05-30
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
ClotTriever System, Commercially available/market approved anticoagulation medication including but not limited to: Heparin Sodium, Coumadin, Rivaroxaban, Apixaban, etc. - Venous Thromboembolism, Deep Venous Thrombosis
Not applicableRecruitingInari Medical3002023-01-062026-09-09
Best Endovenous Treatment, Including STenting, Versus Non-endovenous Treatment in Chronic Proximal Deep Venous Disease
Deep venous stenting, Best medical therapy - Chronic Venous Insufficiency, Chronic Venous Thrombosis
Not applicableTerminatedImperial College London122022-09-032025-06-22
The MUFFIN-PTS Trial
Micronized Purified Flavonoid Fraction, Placebo - Post-Thrombotic Syndrome
Phase 3UnknownSir Mortimer B. Davis - Jewish General Hospital882022-02-042023-11-30
Tinzaparin Lead-In to Prevent the Post-Thrombotic Syndrome
tinzaparin, Rivaroxaban - Deep Vein Thrombosis, Post Thrombotic Syndrome
Phase 4TerminatedSunnybrook Health Sciences Centre92021-11-152024-04-04

Showing 20 of 72. Sign in to see all of them.

Narrower conditions

Venous Thrombosis (49)  ·  Venous Thromboembolism (8)  ·  Thrombosis (7)  ·  Postphlebitic Syndrome (6)  ·  Varicose Ulcer (5)  ·  Venous Insufficiency (5)  ·  Inflammation (3)  ·  May-Thurner Syndrome (3)  ·  Pulmonary Embolism (3)  ·  Edema (2)  ·  Motor Activity (2)  ·  Behcet Syndrome (1)  ·  Cardiovascular Diseases (1)  ·  Disease (1)

Broader conditions

Vascular Diseases (72)  ·  Cardiovascular Diseases (71)  ·  Embolism and Thrombosis (71)  ·  Venous Insufficiency (67)  ·  Thrombosis (65)  ·  Venous Thrombosis (23)  ·  Peripheral Vascular Diseases (10)  ·  Pathological Conditions, Signs and Symptoms (8)  ·  Thromboembolism (8)  ·  Phlebitis (6)  ·  Skin Diseases (6)  ·  Skin and Connective Tissue Diseases (6)  ·  Leg Ulcer (5)  ·  Pathologic Processes (5)  ·  Skin Ulcer (5)

Interventions

Rivaroxaban (4)  ·  Exercise (3)  ·  Tissue Plasminogen Activator (3)  ·  Colchicine (2)  ·  Exercise Test (2)  ·  Rosuvastatin Calcium (2)  ·  Stents (2)  ·  Tinzaparin (2)  ·  Anticoagulants (1)  ·  Conversion to Open Surgery (1)  ·  Diosmin (1)  ·  Enoxaparin (1)  ·  Fibrinolytic Agents (1)  ·  Fitness Trackers (1)  ·  Hematologic Tests (1)

Sponsors

Maastricht University Medical Center (4)  ·  Sir Mortimer B. Davis - Jewish General Hospital (4)  ·  Imperial College London (3)  ·  RenJi Hospital (3)  ·  Guy's and St Thomas' NHS Foundation Trust (2)  ·  Intervene, Inc. (2)  ·  Laboratoires Innothera (2)  ·  Ottawa Hospital Research Institute (2)  ·  University Hospital, Montpellier (2)  ·  University of Vermont (2)  ·  University of Zurich (2)  ·  Washington University School of Medicine (2)  ·  Aalborg University Hospital (1)  ·  Aarhus University Hospital (1)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)

Countries

United States (20)  ·  Canada (10)  ·  France (10)  ·  United Kingdom (8)  ·  Netherlands (7)  ·  Switzerland (5)  ·  Austria (3)  ·  China (3)  ·  Germany (3)  ·  Norway (3)  ·  Australia (2)  ·  Denmark (2)  ·  Ireland (2)  ·  Israel (2)  ·  Italy (2)

Top investigators

Nils Kucher, Prof. Dr. med. (2)  ·  Stephen Black, MD (2)  ·  Suresh Vedantham, M.D. (2)  ·  Susan R. Kahn, M.D., M.Sc. (2)  ·  Alun Davies, MA DM FRCS FHEA (1)  ·  Alun Davies, PhD (1)  ·  Alun H Davies (1)  ·  Ayesha Zia, M.D (1)  ·  Benedicte Laursen, MD, DMSc (1)  ·  Brajesh K Lal, MD (1)  ·  Cees Wittens, MD, PhD (1)

Results publications

PMID 39968829, PMID 19017588, PMID 29211671, PMID 36455606, PMID 11028492, PMID 12217281, PMID 15866245, PMID 19224134, PMID 20047905, PMID 20347543, PMID 20578224, PMID 21256773, PMID 21325669, PMID 22172244, PMID 22277690, PMID 22545895, PMID 23537968, PMID 24315521, PMID 24558028, PMID 24722790, PMID 25047081, PMID 25183442, PMID 25246013, PMID 25579875, PMID 25593121, PMID 26853645, PMID 26992578, PMID 26992609, PMID 27061685, PMID 27919609, PMID 28440041, PMID 29550177, PMID 29856509, PMID 30237155, PMID 30314712, PMID 30391776, PMID 30586751, PMID 30667348, PMID 30699446, PMID 31354089, PMID 31592728, PMID 31659739, PMID 31843251, PMID 31983322, PMID 32113854, PMID 32780844, PMID 33201130, PMID 33272030, PMID 33313464, PMID 33445952

NIH funding

K23HL132054 (1), R01HL083926 (1), R01HL137913 (1), U01HL088476 (1), U01HL130048 (1)